Finally, we explored the potential association of plasma-derived EV levels of ADAM10, CD59, TSPAN9 and plasma CEA with different clinicopathological characteristics, including gender, age, TNM stage, tumor stage, lymph node metastasis and distant metastasis, of enrolled CRC patients (Table 3). This evidence concerns the gene CD59 and metastatic malignant neoplasm in the lymph nodes.